4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034428
EVP, Head of R&D sold 5,184 shares at $14.55 ($75,427)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dupont Jakob EVP, Head of R&D | 2021-05-18 | Sale | −5,184 | $14.55 | $75,427 | 94,945 | D: show line 1 in the form |
| Open-market sales · 5,184 sh · avg $14.55 · $75,427 | |||||||
Loading xslF345X03/doc4.xml…